Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Vitasora Health Limited (VHLUF : OTC)

• Company Description    Vitasora Health Limited is an e-health SaaS company, researches, develops and commercializes medical devices. Vitasora Health Limited, formerly known as Respiri Limited, is based in Melbourne, Australia. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $ Daily Weekly Monthly 20 Day Moving Average: shares Shares Outstanding: (millions) Market Capitalization: $ (millions) Beta: 52 Week High: $0.06 52 Week Low: $0.06 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week % % 12 Week % % Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 432 St Kilda Road Suite 1 Level 9 - Melbourne,VI 3004 AUS ph: 61-3-9653-9160 fax: 61 -0-3 9602 3606 None https://vitasorahealth.com.au

• General Corporate Information    Officers Marjan Mikel - Cheif Executive Officer Nicholas Smedley - Chairman of the Board Peter Hildebrandt - Chief Operating Officer Samaneh Sarraf Shirazi - Chief Research Officer Jonathan Adams - Non-Executive Director Peer Information Vitasora Health Limited (ABMD) Vitasora Health Limited (DMDS) Vitasora Health Limited (CPWY.) Vitasora Health Limited (EQUR) Vitasora Health Limited (ECIA) Vitasora Health Limited (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: Q8124J104 SIC: 8880 Fiscal Year Fiscal Year End: June Last Reported Quarter: - Next Expected EPS Date: 01/12/26 Share - Related Items Shares Outstanding: Most Recent Split Date: 7.00 (0.05:1) Beta: Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: % Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 01/12/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 12/31/25 - - 09/30/25 - - 06/30/25 - - ROA 12/31/25 - - 09/30/25 - - 06/30/25 - - Current Ratio 12/31/25 - - 09/30/25 - - 06/30/25 - 1.46 Quick Ratio 12/31/25 - - 09/30/25 - - 06/30/25 - 0.67 Operating Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - - 09/30/25 - - 06/30/25 - -272.74 Book Value 12/31/25 - - 09/30/25 - - 06/30/25 - - Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - 0.00 Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - 0.00

Powered by Zacks Investment Research ©